Principal Financial Group’s DIPLOMAT PHARMACY, INC. DPLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q1 | – | Sell |
-456,180
| Closed | -$1.82M | – | 2280 |
|
|
2019
Q4 | $1.82M | Buy |
456,180
+1,630
| +0.4% | +$7.66K | ﹤0.01% | 1741 |
|
|
2019
Q3 | $2.23M | Sell |
454,550
-855
| -0.2% | -$4.78K | ﹤0.01% | 1702 |
|
|
2019
Q2 | $2.77M | Buy |
455,405
+568
| +0.1% | +$3.02K | ﹤0.01% | 1670 |
|
|
2019
Q1 | $2.64M | Sell |
454,837
-4,685
| -1% | -$48.4K | ﹤0.01% | 1694 |
|
|
2018
Q4 | $6.18M | Sell |
459,522
-12,637
| -3% | -$213K | 0.01% | 1425 |
|
|
2018
Q3 | $9.16M | Buy |
472,159
+85,299
| +22% | +$1.82M | 0.01% | 1373 |
|
|
2018
Q2 | $9.89M | Buy |
386,860
+17,837
| +5% | +$416K | 0.01% | 1314 |
|
|
2018
Q1 | $7.44M | Buy |
369,023
+8,258
| +2% | +$193K | 0.01% | 1398 |
|
|
2017
Q4 | $7.24M | Buy |
360,765
+197
| +0.1% | +$3.87K | 0.01% | 1426 |
|
|
2017
Q3 | $7.47M | Buy |
360,568
+28,343
| +9% | +$479K | 0.01% | 1408 |
|
|
2017
Q2 | $4.92M | Buy |
332,225
+2,372
| +0.7% | +$39.5K | ﹤0.01% | 1557 |
|
|
2017
Q1 | $5.26M | Buy |
329,853
+15,576
| +5% | +$225K | 0.01% | 1513 |
|
|
2016
Q4 | $3.96M | Sell |
314,277
-7,984
| -2% | -$149K | 0.01% | 1590 |
|
|
2016
Q3 | $9.03M | Buy |
322,261
+60,797
| +23% | +$2.04M | 0.01% | 1179 |
|
|
2016
Q2 | $9.15M | Buy |
261,464
+19,056
| +8% | +$599K | 0.01% | 1114 |
|
|
2016
Q1 | $6.64M | Buy |
+242,408
| New | +$7.14M | 0.01% | 1240 |
|
|
2015
Q3 | – | Sell |
-5,454
| Closed | -$244K | – | 2234 |
|
|
2015
Q2 | $244K | Buy |
+5,454
| New | +$205K | ﹤0.01% | 1995 |
|
Other funds holding DPLO
Principal Financial Group's DPLO Position: Q1 2020 in Review
Principal Financial Group sold out of DIPLOMAT PHARMACY, INC. (DPLO) in Q1 2020, closing a stake of 456,180 shares — an estimated $1.82M sold.
Principal Financial Group first reported a position in DPLO in Q2 2015 and held it in 17 quarters. The position peaked at $9.89M in Q2 2018. 1 fund tracked by Wall St. Rank holds DPLO as of Q1 2020.
- Principal Financial Group reported no remaining DIPLOMAT PHARMACY, INC. position as of Q1 2020 after selling out during the quarter.
- Principal Financial Group sold 456,180 DIPLOMAT PHARMACY, INC. shares in Q1 2020, an estimated $1.82M.
- Principal Financial Group first reported a position in DIPLOMAT PHARMACY, INC. in Q2 2015 and held it in 17 quarters.
- Principal Financial Group's DIPLOMAT PHARMACY, INC. position peaked at $9.89M in Q2 2018.
- 1 fund tracked by Wall St. Rank held DIPLOMAT PHARMACY, INC. as of Q1 2020.
Based on Principal Financial Group's 13F filing for Q1 2020, filed 12 May 2020.